Insiders who reported open-market trades in the last 12 months at the companies Robert P. Ragusa files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Robert P. Ragusa is a corporate insider, tracked as Director of Alamar Biosciences, Inc. (ALMR). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert P. Ragusa submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Robert P. Ragusa been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($17.92M) across all tracked filings.
Robert P. Ragusa is Director of Alamar Biosciences, Inc. (ALMR). 11 SEC Form 4 filings on record going back to 2024, most recently on 3 September 2026. Most recent open-market trade: sold $6.16M of GRAL on 9 April 2026. Lifetime open-market sales: $17.92M.
Recent transactions
18
The latest 18 SEC Form 4 transactions reported by Robert P. Ragusa.
InsiderAlpha's records for Robert P. Ragusa go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
